Enzyme and Hormone Biochemistry

Enzyme and Hormone Biochemistry: Core Concepts for Medical Students

Learning Objectives

By the end of this module you will be able to:

• Distinguish between different types of enzyme specificity.
• Explain substrate inhibition and its kinetic implications.
• Identify the role of NADH in the lactate dehydrogenase reaction.
• Apply the induced‑fit model to mutations that affect enzyme flexibility.
• Classify hormones by their solubility and receptor location.
• Describe the negative‑feedback loop governing thyroid‑hormone secretion.
• Interpret elevated creatine kinase (CK) levels in a clinical context.
• Differentiate between prosthetic groups, coenzymes, and metal cofactors.

1. Enzyme Specificity

Enzymes are remarkable catalysts that accelerate biochemical reactions with extraordinary precision. The degree of this precision is described as enzyme specificity. Four major categories are recognized:

• Group specificity: the enzyme acts on a particular functional group (e.g., alcohol dehydrogenase oxidizes primary alcohols).
• Linkage specificity: the enzyme cleaves a specific type of bond, such as peptide bonds in proteases.
• Stereochemical specificity: the enzyme distinguishes between stereoisomers, often producing a single enantiomer.
• Absolute specificity: the enzyme catalyzes only one reaction with a single substrate. This is the most stringent form of specificity and is the correct answer to the quiz question about “catalyzing only one specific reaction.”

Understanding absolute specificity is essential for drug design, as inhibitors must fit the enzyme’s active site with high fidelity.

2. Substrate Inhibition: When Too Much Is Harmful

Enzyme kinetics are commonly described by the Michaelis–Menten model, which predicts that reaction velocity increases with substrate concentration until a plateau (V_max) is reached. However, at very high substrate concentrations, some enzymes exhibit substrate inhibition. In this scenario, excess substrate binds to a secondary site on the enzyme, interfering with catalysis.

The quiz scenario—adding excess substrate and observing a decreased rate—illustrates substrate inhibition due to competition for active sites. This phenomenon is distinct from product inhibition, allosteric activation, or denaturation, which were listed as distractors.

Key points to remember:

• Substrate inhibition often follows the equation: V = (Vmax [S]) / (Km + [S] + ([S]^2 / Ki)), where Ki is the inhibition constant.
• It is observed in enzymes such as hexokinase and certain dehydrogenases.
• Clinically, substrate inhibition can affect drug metabolism when drug concentrations become supratherapeutic.

3. Role of NADH in the Lactate Dehydrogenase (LDH) Reaction

LDH catalyzes the interconversion of pyruvate and lactate, coupling this conversion to the oxidation‑reduction of the nicotinamide adenine dinucleotide pair:

Pyruvate + NADH ⇌ Lactate + NAD⁺

In this reaction, NADH functions as a coenzyme loosely bound to the apoenzyme. It is not permanently attached (as a prosthetic group) nor is it a metal cofactor. The transient association allows NADH to shuttle electrons efficiently while remaining available for subsequent catalytic cycles.

Clinical relevance: Elevated LDH levels, together with altered NADH/NAD⁺ ratios, can indicate tissue hypoxia or hemolysis.

4. Enzyme Flexibility and the Induced‑Fit Model

Traditional “lock‑and‑key” theory suggested that enzymes and substrates fit perfectly without conformational change. Modern evidence supports the induced‑fit model, where substrate binding induces a structural rearrangement that optimizes catalytic activity.

A mutation that reduces the flexibility of the active site will therefore:

• Limit the enzyme’s ability to adopt the optimal conformation.
• Decrease catalytic efficiency, reflected by a lower kcat and possibly an increased Km.

The quiz correctly identifies the induced‑fit model with reduced catalytic efficiency as the most appropriate kinetic prediction.

5. Hormone Classification: Lipophilic vs. Hydrophilic

Hormones are broadly divided based on solubility:

• Hydrophilic hormones (e.g., epinephrine, insulin, glucagon) cannot cross the plasma membrane and act via cell‑surface receptors.
• Lipophilic hormones (e.g., steroid hormones such as testosterone, estrogen, cortisol) readily diffuse through the lipid bilayer and bind intracellular receptors that function as transcription factors.

The quiz question asks which hormone is lipophilic and binds intracellular receptors; the correct answer is testosterone.

6. Negative Feedback in Thyroid‑Hormone Regulation

The hypothalamic‑pituitary‑thyroid (HPT) axis exemplifies classic negative feedback:

1. The hypothalamus releases thyrotropin‑releasing hormone (TRH).
2. TRH stimulates the anterior pituitary to secrete thyroid‑stimulating hormone (TSH).
3. TSH prompts the thyroid gland to produce thyroxine (T4) and triiodothyronine (T3).
4. Elevated circulating T3/T4 inhibit further release of TRH and TSH.

Thus, the statement “Elevated T3/T4 levels suppress further release of TRH and TSH” accurately reflects the negative‑feedback loop.

7. Clinical Interpretation of Elevated Creatine Kinase (CK)

Creatine kinase is an enzyme that catalyzes the reversible transfer of a phosphate group from phosphocreatine to ADP, forming ATP. CK isoforms are tissue‑specific:

• CK‑MB: cardiac muscle
• CK‑MM: skeletal muscle
• CK‑BB: brain

Markedly elevated CK, especially the CK‑MB fraction, is most consistent with recent myocardial infarction. While other conditions (e.g., strenuous exercise, muscular dystrophy) can raise CK, the quiz focuses on the acute cardiac event as the primary association.

8. Cofactor Types: Prosthetic Groups vs. Others

Cofactors enhance enzyme activity and are classified by their binding strength:

• Prosthetic groups are tightly, often covalently, bound to the enzyme (e.g., heme in cytochrome P450, flavin adenine dinucleotide in succinate dehydrogenase).
• Coenzymes are loosely associated and may dissociate after each catalytic cycle (e.g., NAD⁺, coenzyme A).
• Metal ions can act as catalytic or structural cofactors but are not covalently attached.

The quiz correctly identifies a prosthetic group as the cofactor type most likely to be covalently bound.

9. Integrating Knowledge: Case‑Based Application

Consider a patient presenting with chest pain, elevated CK‑MB, and a laboratory report indicating high substrate concentrations in an enzyme assay of LDH. Applying the concepts covered:

1. Elevated CK‑MB confirms myocardial injury.
2. High substrate levels causing decreased LDH activity suggest substrate inhibition, a reminder that enzyme assays must be performed within optimal substrate ranges.
3. If the patient were receiving a steroid medication (e.g., testosterone), its lipophilic nature would allow intracellular receptor binding, potentially influencing gene expression related to cardiac remodeling.

This integrated approach demonstrates how biochemical principles translate to clinical decision‑making.

10. Summary and Key Take‑aways

• Absolute specificity denotes an enzyme that catalyzes a single reaction.
• Substrate inhibition occurs when excess substrate binds to secondary sites, reducing reaction velocity.
• NADH is a loosely bound coenzyme in the LDH reaction.
• Mutations affecting active‑site flexibility are best explained by the induced‑fit model.
• Testosterone exemplifies a lipophilic hormone that acts via intracellular receptors.
• Elevated T3/T4 suppress TRH and TSH release through negative feedback.
• Marked CK elevation most often signals myocardial infarction.
• Prosthetic groups are covalently attached cofactors.

Further Reading and Resources

To deepen your understanding, explore the following reputable sources:

• Biochemistry (Nelson & Cox) – Chapter on Enzyme Kinetics
• American Thyroid Association – Guidelines on Thyroid Hormone Regulation
• American Heart Association – CK Test Interpretation

By mastering these concepts, you will be better equipped to analyze biochemical data, understand hormone action, and apply this knowledge in both academic and clinical settings.